"BRIEF-Vertex Pharmaceuticals files for potential mixed shelf
— 5:48 PM ET 05/03/2016
May 3 (Reuters) - Vertex Pharmaceuticals Inc
* Files for potential mixed shelf; size not disclosed - SEC filing Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)"
Apparently investors do not think that is a positive development.
Yes, the analysts estimate was a loss of $.23. revenue was 58.9M vs analysts estimate of 43.78M.